Lisa Lipp, Stephan Schmid, Sophia Rusch, Peter Malfertheiner, Martina Müller, Michael Selgrad
{"title":"Prevalence of Helicobacter pylori and its Association with Extragastric Diseases in a Tertiary Hospital from East Bavaria.","authors":"Lisa Lipp, Stephan Schmid, Sophia Rusch, Peter Malfertheiner, Martina Müller, Michael Selgrad","doi":"10.15403/jgld-6107","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori (H. pylori) infection remains a significant burden in gastroduodenal diseases. However, contemporary data on the prevalence of H. pylori infection in Germany are limited.</p><p><strong>Aim: </strong>This study aimed to evaluate the current seroprevalence of H. pylori infection in the East Bavarian region by analyzing antibody levels in patients presenting to a German university hospital.</p><p><strong>Methods: </strong>Serum samples were collected from both inpatients and outpatients of a German university hospital. H. pylori antibody concentrations were measured using a commercially available assay.</p><p><strong>Results: </strong>The overall prevalence of H. pylori infection was 24.8% (78/314), with the highest infection rates observed in individuals aged over 60 years. A significant association was found between H. pylori infection and liver cirrhosis, with a prevalence of 36.4% (36/99) in patients with liver cirrhosis compared to 19.5% (42/215) in those without liver cirrhosis (p = 0.002). No significant associations were observed between H. pylori infection and type 2 diabetes or coronary artery disease.</p><p><strong>Conclusion: </strong>This study highlights a low prevalence in H. pylori seropositivity in the eastern part of Bavaria. In patients with liver cirrhosis, we still see a considerable high prevelance of H. pylori. The findings underscore the importance of continued surveillance to monitor trends in H. pylori prevalence and its associations with extragastric diseases.</p>","PeriodicalId":94081,"journal":{"name":"Journal of gastrointestinal and liver diseases : JGLD","volume":"34 2","pages":"163-166"},"PeriodicalIF":2.0000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastrointestinal and liver diseases : JGLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15403/jgld-6107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Helicobacter pylori (H. pylori) infection remains a significant burden in gastroduodenal diseases. However, contemporary data on the prevalence of H. pylori infection in Germany are limited.
Aim: This study aimed to evaluate the current seroprevalence of H. pylori infection in the East Bavarian region by analyzing antibody levels in patients presenting to a German university hospital.
Methods: Serum samples were collected from both inpatients and outpatients of a German university hospital. H. pylori antibody concentrations were measured using a commercially available assay.
Results: The overall prevalence of H. pylori infection was 24.8% (78/314), with the highest infection rates observed in individuals aged over 60 years. A significant association was found between H. pylori infection and liver cirrhosis, with a prevalence of 36.4% (36/99) in patients with liver cirrhosis compared to 19.5% (42/215) in those without liver cirrhosis (p = 0.002). No significant associations were observed between H. pylori infection and type 2 diabetes or coronary artery disease.
Conclusion: This study highlights a low prevalence in H. pylori seropositivity in the eastern part of Bavaria. In patients with liver cirrhosis, we still see a considerable high prevelance of H. pylori. The findings underscore the importance of continued surveillance to monitor trends in H. pylori prevalence and its associations with extragastric diseases.